Imexpharm Corporation (HOSE: IMP)

Imexpharm Market Cap

Imexpharm has a market cap or net worth of 6.44 trillion as of November 21, 2024. Its market cap has increased by 57.20% in one year.

• Market Cap: 6.44T
• Enterprise Value: 6.27T
• Revenue: 2.16T
• Ranking: n/a
• PE Ratio: 28.04
• Stock Price: 41,400.00

Market Cap Chart

Since April 2, 2007, Imexpharm's market cap has increased from 1.11T to 6.44T, an increase of 480.59%. That is a compound annual growth rate of 10.48%.

Market Cap History

Date	Market Cap	% Change
Nov 21, 2024	6,375.97B	60.92%
Dec 29, 2023	3,962.17B	-1.28%
Dec 30, 2022	4,013.63B	-22.62%
Dec 31, 2021	5,187.05B	38.19%
Dec 31, 2020	3,753.61B	58.34%
Dec 31, 2019	2,370.59B	-21.20%